Evidence map›Paper›PMID 41868164›Full record

ArticleChemical science2026

Highly stereoselective synthesis of allylic β-lactams

Nawal Zahra Jafari, Zheyuan Wang, Anwita Chattopadhyay, Satyajit Roy, Rudi Fasan

Abstract read
In one paragraph

Article in Chemical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nawal Zahra JafariDepartment of Chemistry and Biochemistry, The University of Texas at Dallas Richardson TX 75080 USA rudi.fasan@utdallas.edu.ORCID https://orcid.org/0009-0000-4518-1325
Zheyuan WangDepartment of Chemistry and Biochemistry, The University of Texas at Dallas Richardson TX 75080 USA rudi.fasan@utdallas.edu.ORCID https://orcid.org/0009-0003-8116-0419
Anwita ChattopadhyayDepartment of Chemistry and Biochemistry, The University of Texas at Dallas Richardson TX 75080 USA rudi.fasan@utdallas.edu.ORCID https://orcid.org/0000-0003-1294-7552
Satyajit RoyDepartment of Chemistry and Biochemistry, The University of Texas at Dallas Richardson TX 75080 USA rudi.fasan@utdallas.edu.ORCID https://orcid.org/0000-0001-7374-4797
Rudi FasanDepartment of Chemistry and Biochemistry, The University of Texas at Dallas Richardson TX 75080 USA rudi.fasan@utdallas.edu.ORCID https://orcid.org/0000-0003-4636-9578

Funding

Chemoenzymatic Strategies for Molecular Discovery and Asymmetric SynthesisR35GM158365 · NIGMS · UNIVERSITY OF TEXAS DALLAS · PI Rudi Fasan · 2025 to 2026
$1.2M
NIGMS NIH HHS R35 GM158365
6 · The paper itself

Abstract

β-Lactams are versatile synthons for organic synthesis as well as valuable pharmacophores for drug development. Here, we describe a biocatalytic strategy for the enantioselective synthesis of allylic β-lactams

Identifiers

PMID41868164
PMCPMC13001667

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.